Tci Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tci Co Ltd with three other
pharmaceutical manufacturers in Asia:
Formosa Laboratories, Inc
sales of 3.19 billion Taiwanese Dollars [US$104.96 million]
of which 100%
was Active Pharmaceutical Ingredient),
Ind-Swift Laboratories Limited
(6.53 billion Indian Rupees [US$99.95 million]
Wakamoto Pharmaceutical Co., Ltd.
based in Japan
(11.18 billion Japanese Yen [US$99.31 million]
of which 51%
was Medical Pharmaceutical Products).
Tci Co Ltd reported sales of 3.11 billion Taiwanese Dollars (US$102.34 million)
December of 2016.
increase of 50.6%
versus 2015, when the company's sales were 2.06 billion Taiwanese Dollars.
Sales at Tci Co Ltd have increased during each of the previous five years
(and since 2011, sales have increased a total of 223%).
Sales of Asia saw an increase
78.7% in 2016, from
1.14 billion Taiwanese Dollars to 2.04 billion Taiwanese Dollars.